Telemedicine Adoption in Low and Middle Income Countries: A Review of Barriers, Opportunities, and Outcomes
DOI:
https://doi.org/10.47747/icbem.v3i1.3269Keywords:
Telemedicine, Adoption, Lmics, Barriers, Opportunities, OutcomesAbstract
Telemedicine is increasingly recognized as an effective way to expand healthcare access in low and middle income countries (LMICs), where long travel distances, workforce shortages, and limited infrastructure continue to hinder timely care. Despite its promise, many LMICs still face substantial challenges in implementing telemedicine consistently and at scale. This review synthesizes recent evidence to clarify the barriers that limit successful adoption, the factors that enable progress, and the outcomes observed when telemedicine is applied in real-world LMIC settings. A narrative review approach was used to examine peer-reviewed studies published between 2015 and 2025. A structured search across PubMed, Scopus, and Web of Science identified 798 articles. After screening for relevance to telemedicine implementation in LMICs, 15 studies were included. Narrative synthesis was then applied to integrate findings and identify recurring implementation challenges, enabling conditions, and reported impacts on patient care and health-system performance. The findings reveal persistent obstacles, including limited internet capacity, unstable electricity supply, unclear regulatory frameworks, and low digital literacy among patients and healthcare providers. At the same time, several positive developments, such as national digital-health strategies, mobile-first platforms designed for low-bandwidth environments, and capacity building initiatives are creating more supportive conditions for adoption. Evidence across a range of clinical areas shows improvements in continuity of care, reduced travel burden, higher patient satisfaction, and clinical outcomes comparable to in-person services. However, methodological heterogeneity and limited economic evaluations constrain understanding of long-term sustainability. Overall, current evidence suggests that telemedicine can strengthen health systems in LMICs, provided that sustained investments in infrastructure, governance, and digital competencies are prioritized
References
Adenuga, K. I., Iahad, N. A., & Miskon, S. (2017). Reinforcing telemedicine adoption among clinicians in Nigeria. International Journal of Medical Informatics, 104, 84–96. https://doi.org/10.1016/j.ijmedinf.2017.05.008.
Alami, H., et al. (2020). Telemedicine governance and ethics in LMICs. Health Policy and Technology, 9(3), 100446. https://doi.org/10.1016/j.hlpt.2020.100446
Combi, C., Pozzani, G., & Pozzi, G. (2016). Telemedicine for developing countries. Applied Clinical Informatics, 7(4), 1025–1050. https://doi.org/10.4338/ACI-2016-06-R-0089
Dodoo, J. E., Al-Samarraie, H., & Alsswey, A. (2022). Telemedicine programs in Sub-Saharan Africa. Health and Technology, 12, 33–46. https://doi.org/10.1007/s12553-021-00626-7
Garg, R., et al. (2024). A 12-month randomized controlled trial assessing telemedicine impact. Cureus, 16(1), e53201. https://doi.org/10.7759/cureus.53201
Kruse, C. S., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018). Evaluating barriers to telemedicine worldwide. Journal of Telemedicine and Telecare, 24(1), 4–12. https://doi.org/10.1177/1357633X16674087
Kruse, C. S., Stein, A., Thomas, H., & Kaur, H. (2022). Barriers to telehealth adoption during COVID-19. Journal of Medical Internet Research, 24(1), e31752. https://doi.org/10.2196/31752
Mahmoud, K., Jaramillo, C., & Barteit, S. (2022). Telemedicine in LMICs during COVID-19. Frontiers in Public Health, 10, 914423. https://doi.org/10.3389/fpubh.2022.914423
Page, M. J., et al. (2021). The PRISMA 2020 statement. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Shiferaw, K. B., & Mehari, E. A. (2019). Digital health infrastructure challenges. BMC Medical Informatics, 19, 181. https://doi.org/10.1186/s12911-019-0870-4
Smith, A. C., Thomas, E., Snoswell, C., et al. (2020). Telehealth for global health systems. Journal of Telemedicine and Telecare, 26(5), 309–313. https://doi.org/10.1177/1357633X20916567
Wootton, R. (2020). Telemedicine in the time of COVID-19. Journal of Telemedicine and Telecare, 26(6), 329–333. https://doi.org/10.1177/1357633X20937765
Ye, J., He, L., & Beestrum, M. (2023). Telehealth implementation in developing countries. npj Digital Medicine, 6, 174. https://doi.org/10.1038/s41746-023-00908-6
Narasimhan, M., et al. (2023). Barriers and enablers to telemedicine adoption in low-resource settings: A global mixed-methods review. The Lancet Digital Health, 5(2), e123–e135. https://doi.org/10.1016/S2589-7500(22)00210-5
Mwangi, J., et al. (2024). Cost-effectiveness of telemedicine interventions in low- and middle-income countries: A systematic review. Journal of Global Health, 14, 04015. https://doi.org/10.7189/jogh.14.04015